News

The pivotal phase III clinical trial was a multi-center, world-wide, randomized, double-blind, parallel group, dose-ranging study, to assess the safety and efficacy of taliglucerase alfa in 31 treatment-naive

SafeBridge now has a validated method that will detect as low as 20 picograms per filter in an air sample collected on appropriate media. This limit of detection

Dr Feingold’s experience in oncology and hematology will continue to drive the DSI’s current cardiovascular portfolio and shape its pipeline. He will also become a member of DSI’s

Benicar is an angiotensin II receptor blocker (ARB), which blocks the action of a substance in the body called angiotensin II that increases blood pressure. It is indicated

Additionally, he will also work directly with Nutra Pharma licensees to coordinate ongoing marketing and outreach initiatives for the company’s drug pipeline, including its recently launched pain relievers,

Under the terms of the agreement, Qiagen will have worldwide rights to distribute this multiplex test kit, which will be manufactured by Celera. The new ResPlex assay detects

Reportedly, the study population will consist of patients ages 18 to 75 with symptoms of angina or myocardial ischemia. The primary endpoints are difference in Major Adverse Cardiac

Previously, Javelin had reported that the top line results for its primary endpoint were not significant. The previously disclosed top line results, based upon data captured by an

The SPA is a written agreement between NewLink as the trial sponsor and the FDA regarding the design, endpoints, and planned statistical analysis of a Phase 3 trial